Assessment of the prevalence of low-dose aspirin-induced (LDA) small bowel injury in chronic LDA users

Assessment of the prevalence of low-dose aspirin-induced (LDA) small bowel injury in chronic LDA users - The prevalence of small bowel injury in chronic LDA users

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000008550

Enrollment

300

Registered

2012-07-27

Start date

2012-07-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

small bowel mucosal injury

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with chronic LDA use (more than three months) prior this study 2. Willingness to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. History of NSAIDs use within three months prior this study 2. History of inflammatory bowel disease 3. History of severe renal failure and/or hepatic failure 4. Patients with implantable pacemaker 5. Ppatients with dysphagia. 6. Patients who have history of the ileus or stricture or fistula of the intestine. 7. Patients who can not give informed consent for operation to retrieve the capsule. 8. The patients who have severe heart failure and respiratory failure. 9. Patients judged as inappropriate candidates for the trial by the investigators

Design outcomes

Primary

Measure	Time frame
The prevalence and numbers of low-dose aspirin-induced small bowel erosions and ulcerations evaluated by capsule endoscopy	—

Countries

Japan

Outcome results